ABBV
50
8
MO
65
5
ROK
64
-2
AEP
58
4
CVS
52
-6
LB
60
4
XOM
40
-7
SRE
45
-9
STZ
52
-5
FFIV
69
2
WDC
63
13
SYK
68
4
ORLY
66
4
NWS
60
-4
URBN
50
-2
KO
47
-2
MOS
43
-5
PLD
56
-5
MAT
41
-4
ETR
72
3
ABBV
50
8
MO
65
5
ROK
64
-2
AEP
58
4
CVS
52
-6
LB
60
4
XOM
40
-7
SRE
45
-9
STZ
52
-5
FFIV
69
2
WDC
63
13
SYK
68
4
ORLY
66
4
NWS
60
-4
URBN
50
-2
KO
47
-2
MOS
43
-5
PLD
56
-5
MAT
41
-4
ETR
72
3
Financhill
Back

ProShares VIX Short-Term Futures Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
18

VIXY
ProShares VIX Short-Term Futures

Last Price:
43.71
Seasonality Move:
-13.31%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.49
Seasonality Move:
14.88%
Sell
18
ProShares VIX Short-Term Futures (VIXY) is a Sell

Is ProShares VIX Short-Term Futures a Buy, Sell or Hold?

  • The current ProShares VIX Short-Term Futures [VIXY] share price is $43.01. The Score for VIXY is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • VIXY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VIXY Stock Price Chart

What is ProShares VIX Short-Term Futures's stock price today?

  • The ProShares VIX Short-Term Futures share price today is $43.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VIXY is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

VIXY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.8 Sell
Relative Strength Index (14 RSI): 38.61 Sell
Chaikin Money Flow: -21037 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.57 - 52.77) Sell
Bollinger Bands (100): (42.7 - 56.1) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

VIXY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.21 Sell
20-day SMA: 47.04 Sell
50-day SMA: 49.63 Sell
200-day SMA: 50.15 Sell
8-day EMA: 44.78 Sell
20-day EMA: 46.49 Sell
50-day EMA: 48.46 Sell
200-day EMA: 56.66 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

ProShares VIX Short-Term Futures Earnings Growth & VIXY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

ProShares VIX Short-Term Futures Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):